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Background: The aim of this systematic study was to investigate patient outcomes and nutritional deficiencies
following sleeve gastrectomy (SG) during a median follow-up of two years.
Methods: Over a period of 56 months, all consecutive patients who underwent SG were documented in this
prospective, single-center, observational study. The study endpoints included complication rates, nutritional
deficiencies and percentage of excess weight loss (%EWL).
Results: From September 26, 2005 to May 28, 2009, 100 patients (female: male = 59:41) with a mean age of
43.6 years (range: 22–64) and a preoperative BMI of 52.3 kg/m² (range: 36–77) underwent SG. The mean operative
time was 86.4 min (range: 35–275). Major complications were observed in 8.0 % of the patients. During the follow-
up period, 25 patients (25.0 %) underwent a second bariatric intervention (22 DS and 3 RYGBP). Out of the total 100
patients, 48 % were supplemented with iron, 33 % with zinc, 34 % with a combination of calcium carbonate and
cholecalciferol, 24 % with vitamin D, 42 % with vitamin B12 and 40 % with folic acid. The patients who received
only a SG (n = 75) had %EWL of 53.6, 65.8 and 62.6 % after 6, 12 and 24 months, respectively.
Conclusions: SG is a highly effective bariatric intervention for morbidly obese patients. Nutritional deficiencies
resulting from the procedure can be detected by routine nutritional screening. Results of the study show that
Vitamin B12 supplementation should suggested routinely.
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Nutritional deficienciesBackground
Obesity has developed into an epidemic. Approximately
1.7 billion people are overweight, and 312 million are
obese [1,2]. In Germany in 2009, 60.1 % of male and
42.9 % of female population was overweight [3]. There
are currently no conservative treatments that produce
the %EWL results and stable courses observed following
bariatric surgery. Obesity is associated with an increased
mortality risk [4]. Obesity is also associated with
increased health costs. A BMI = 35 kg/m² is associated
with a 200 % increase in health care costs compared the
normal weight range [5].
As a result of the obesity epidemic bariatric and meta-
bolic surgeries have grown in popularity in recent years,
resulting that the number of operations is rapidly* Correspondence: christine.stroh@wkg.srh.de
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reproduction in any medium, provided the orincreasing. Laparoscopic sleeve Gastrectomy (SG) was
performed as the single step procedure for surgically
induced weight loss in 2000 [6].
SG can be suggested as a first step procedure for mul-
timorbid patients with a BMI> 50 kg/m², considering
the high mortality rate of 6 % following biliopancreatic
diversion (BPD) with DS [7,8]. In literature is the lack of
studies with high evidence levels on SG reporting long
term follow up data, results on reoperation rate or long
term complication rate for surgical complications as well
as nutrient deficiencies.
The aim of the following systematic study was to in-
vestigate nutritional deficiencies and outcomes following
SG during a mean follow up period of two years.Methods
From September 26, 2005 to May 28, 2009, 100 patients
underwent SG in the Surgery Department of the SRHan Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Pech et al. BMC Surgery 2012, 12:13 Page 2 of 7
http://www.biomedcentral.com/1471-2482/12/13Wald-Klinikum Gera Hospital. All patients had to agree
with an informed consent. Data collection and analysis was
performed in compliance with the Helsinki Declaration.
After we ensured compliance with international and
German guidelines all patients had to take part in an in-
formational seminar [9]. Patient´s evaluation was per-
formed by experienced bariatric surgeons.
Data collection took place prospectively and analyzed
retrospectively. Patients were classified according to the
WHO classifications of obesity (35–39.9 kg/m²; 40–
49.9 kg/m²) with expansions to “super obesity” (50–
59.9 kg/m²) and “super-super obesity” (= 60 kg/m²).
Analyzed parameters are listed in Table 1 (Table 1).
Acute and postoperative complications were evaluated.
Sleeve gastrectomy- operation technique
SG was performed in the French position in a 30° re-
verse Trendelenburg position. Pneumoperitoneum was
established to 15 mmHg. First trocar for placing the
camera was inserted 15 cm distal to the xiphoid process.
Another trocar was placed on the epigastric angle for
liver retraction. Two trocars were located on the right
and left upper quadrants. A bougie 31–36 French was
used. The dissection of the greater curve began 5–6 cm
proximal to the pylorus and extended to the angle of
His. Sleeve resection of the stomach was performed
using an Endo GIA stapler (green) made by Covidien,
GermanyW using staple line reinforcement in 88 % of the
patients. Staple line was not oversewn. To exclude leak-
age of staple line a methylene blue test was performed.
The resected stomach was filled with water to determine
the resected gastric volume. Histopathological analysis
was performed on the specimen. In all patients for single
shot antibiosis a third generation cephalosporine was
given.
Postoperative follow up
All of the patients were examined throughout a 24-
month follow-up period (at 3, 6, 12, 18 and 24 months
postoperatively) in our clinical outpatient department.Table 1 Recorded parameters
Age OP duration
Sex Use of staple line reinforcement
Length of hospital stay Bougie size






Hemoglobin Parathyroid hormoneFurthermore, short- and long-term results with regard
to BMI, weight, %EWL and important laboratory para-
meters (iron, zinc, selenium, alkaline phosphatase,
hemoglobin, MCV, albumin, vitamin B12, folic acid, cal-




From September 26, 2005 to May 28, 2009, 100 patients
(sex ratio, females: males = 59:41 [1.4:1]) with a mean
age of 43.6 years (range, 22–64) and a preoperative BMI
of 52.3 kg/m² (range, 36–77) underwent SG. Operation
was performed by three surgeons, operating as a team in
all the 100 recorded operations. Patient´s outcome and
operation time were not influenced by changing the sur-
geon in these team. Demographic data are shown in
Table 2 (Table 2).
Surgical outcome
Operation data Of the 100 patients, 99 underwent pri-
marily laparoscopic surgery. In 6.1 % of these patients (6
of 99), a conversion from laparoscopy to laparotomy was
necessary. In one case, a primary laparotomy was per-
formed because of an abdominal wall hernia, resection
of an anus praeter, subtotal colectomy with an ileorec-
tostomy. Subtotal colectomy was performed due to the
fact of several colon operations in an outside hospital.
Postoperative course of the patient was uneventful. In 4
cases, this conversion was performed because of an in-
sufficient laparoscopic overview with high intraabdom-
inal pressure and in 2 cases due to the fact of
laparoscopically uncontrollable bleeding (Table 3).
The mean operation time was 86.4 min. The mean
resected gastric volume was 995.6 ml. A 34-French cali-
bration tube was used in 89 % of the patients (89). Staple
line reinforcements were used in 88 % of the patients
(88) (Table 2). Comparing leakage rate and bleeding in
patients using staple line reinforcement or oversewing
was no difference.
There were significant differences among the durations
of the OP. When staple line reinforcements were used,
the mean OP duration was 79.3 min, compared to
141.1 min without using staple line reinforcements
(p= 0.010).
A conversion to laparotomy was significantly more ne-
cessary for patients with a BMI> 60 kg/m² compared to
patients with a lower BMI (p> 0.001). The duration of
the OP averaged 70.4 min for patients with a BMI be-
tween 35 and 39.9 kg/m², 70.2 min for patients with a
BMI between 40 and 49.9 kg/m², 92.9 min for patients
with a BMI between 50 and 59.9 kg/m² and 101.2 min
for patients with a BMI> 60 kg/m². Patients with a BMI
Table 2 Data from patients and operations
BMI Total
[kg/m²] 35-39,9 40-49,9 50-59,9 > 60
Sex
Male [%] 62.5 24.1 46.3 45.5 41.0
Female [%] 37.5 75.9 53.7 54.5 59.0
Total [n] 8 29 41 22 100
Mean Age Age range [years] 44.6 33-64 44.3 22-59 43.8 22-58 41.7 25-59 43.6 22-64
Mean BMI BMI range [kg/m²] 38.3 36.0-39.5 44.4 40.0-49.8 53.5 50.0-59.1 65.5 60.0-77.0 52.3 36.0-77.0
Operation
Laparoscopy [%] 100.0 96.6 95,1 81.8 93.0
Laparoscopy with conversion [%] 3.4 2,4 18.2 6.0
Laparotomy [%] 2,4 1.0
Mean Operative time Operative time range [min] 70.4 41-101 70.2 44-120 92.9 35-275 101.2 45-225 86.4 35-275
Mean Resected gastric volume [ml] 785.7 (650–900) 882.4 (600–1200) 1081.8 (500–1700) 1045.5 (700–1700) 995.6 (500–1700)
Bougie size
31 French 3.4 1.0
32 French [%] 12.5 3.4 7,3 9.1 7.0
34 French [%] 75.0 93.1 87,8 90.9 89.0
36 French [%] 12.5 4,9 3.0
Staple line reinforcement [%] 87.5 96.6 85,4 81,8 88.0
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pared to patients with a BMI< 50 kg/m² (95.7 vs. 70.2;
p = 0.001). The resected gastric volume was significantly
higher in patients with BMI> 50 kg/m² compared to
those with BMI< 50 kg/m² (1072.7 vs. 854.2; p= 0.001).
Intraoperative and early postoperative surgical com-
plications Twenty patients (20.0 %) suffered on intrao-
perative or/and postoperative complications (Table 3).
Postoperative complications occurred in 17 patients
(17.0 %). One patient with BMI 55.5 kg/m² died (1.0 %).Table 3 Acute and postoperative complications
Complications (20/100; 20.0 %)














Death 1At the tenth postoperative day patient complained of left
upper abdominal pain. The CT scan showed an insuffi-
cient suture with a subcardial abscess. A CT-guided
puncture ensued. Patient’s cardiac situation worsened
and ARDS developed. Acute complications were
observed significantly more frequently in patients with
BMI> 60 kg/m² (p< 0.001). The major complication
rate was 8 % (Table 3).
Mortality rate Mortality rate after 24 month of total fol-
low up is 2 %. Above mentioned patient died during hos-
pital stay 73 days after operation, due to SIRS and ARDS.
Second patient died several months after SG in fact of his
cardiac situation without any relation to operation.
Follow up data Follow up rate was 80 % (80/100). All of
these patients were clinical examined with a laboratory
test 24 months after SG, so mean follow up time is
24 months.
The mean preoperative BMI of all of the patients
examined was 52.3 kg/m². At the end of the follow up,
there was a significant reduction in BMI to 35.4 kg/m²
(p< 0.0005). The greatest weight loss occurred within
the first 12 postoperative months (52.3 kg/m² to 36.3 kg/
m²). Afterwards we observed a weight loss from 36.3 kg/
m² to 35.4 kg/m² for all of the patients.
The %EWL in the BMI categories between 35 and
39.9 kg/m² and 40 and 49.9 kg/m² was 47.4 % and 47.5 %,
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categories was achieved after 12 (72.6 %) and 24 (74.2 %)
months. Patient´s with a BMI between 35 and 39.9 kg/m²
showed a slight tendency toward increased weight after
this time. Patient´s with a BMI between 40 and 49.9 kg/
m², 50 and 59.9 kg/m² and over 60 kg/m² showed con-
tinuous weight loss throughout the entire 24-month
follow-up period (Table 4). On average, there was a ten-
dency toward increased weight after 18 months. The most
significant weight loss was achieved within the first post-
operative year (p< 0.0005). Regarding the percentage
overweight loss, the highest %EWL of 67.1 % occurred
after 18 months, and after 24 months, there was a further
%EWL of 62.6 %. The highest %EWL of 83.3 % was
observed in patients with a BMI between 35 and 39.9 kg/
m² after 12 and 18 months (Table 4).
Revisional procedures after SG Over the total observa-
tion period of 24 months, a second operation to induce
weight loss was required in 25.0 % (25) of the patients to
develop further weight loss or amelioration on comor-
bidities. Three patients underwent RYGBP and 22
patients DS.
Nutrient deficiencies, laboratory parameters and
supplementation
In patients after SG as a single step procedure a postopera-
tive routine supplementation was not performed. Supple-
mentation was suggested according laboratory examination
performed every 6 months in case of deficiencies.
Iron Iron supplementation was performed in 48 patients
(48.0 %). Seven of these patients developed microcytic
anemia, which required the initiation of iron supplemen-
tation. In 23 of these 48 patients, iron supplementationTable 4 Weight progression (BMI in kg/m²) of patients
without a second operation during the follow-up period
(n =75) and %EWL of patients without a second
operation during the follow-up period
months BMI OP 3 6 12 18 24
35-39.9 kg/m² 38.2 31.0 30.2 27.4 27.5 28.4
40-49.9 kg/m² 44.2 35.0 31.1 29.4 30.0 29.9
50-59.9 kg/m² 53.2 44.0 39.5 37.6 36.9 38.2
≥60 kg/m² 65.6 52.5 48.1 44.0 42.3 43.7
Total 51,0 40.8 38.4 34.4 34.4 35.6
%EWL
35-39,9 kg/m² 53.4 62.5 83.3 83.3 76.3
40-49,9 kg/m² 48.6 67.4 76.4 75.0 74.5
50-59,9 kg/m² 33.6 48.5 54.7 57.3 52.8
≥60 kg/m² 30.3 42.6 52.5 58.6 53.8
Total 40.7 53.6 65.8 67.1 62.6was performed as prophylaxis after RYGBP or DS. The
other 25 patients (25.0 %) 21 of them female were sup-
plemented after SG. Further we examined iron supple-
mentation in fertile woman. Women had a mean age of
42.8 years (25–59). Thirteen of these 21 women
recorded a reduced iron value, and the other 8 women
were supplemented with a combination of folic acid and
iron.
Zinc The highest average value for zinc of 14.70 μmol/L
was determined preoperatively (reference range: 10–
23 μmol/L). There were no significant differences among
the average values in the follow-up period. In total, 33
patients underwent zinc supplementation, and 5 of these
complained of hair loss. Nineteen patients were supple-
mented after RYGBP or DS. Fourteen patients (14.0 %)
were supplemented following SG due to zinc deficiency.
For supplementation patients were given 15 mg Zink daily.
Selenium The highest average value for selenium of
81.60 μg/L (reference range: 50–120 μg/L) was deter-
mined preoperatively. After 3 months, a significant de-
crease to 61.13 μg/L (p< 0.0005) occurred. No other
significant differences were observed over the course of
the follow-up. Due to selenium deficiency in laboratory
eight patients after SG were treated with selenium sup-
plementation using 100 μg twice a day. Among the 75
patients who did not undergo a second operation, there
was a gradual increase in the concentration of selenium
(OP: 81.5 μg/L; 3rd month: 62.1 μg/L; 6th month:
63.0 μg/L; 12th month: 66.9 μg/L; 18th month: 66.8 μg/L;
24th month: 69.7 μg/L). The increase in selenium from
3 months after the operation achieved a significant level
after 12 months (p= 0.043).
Calcium and parathyroid hormone In 62 of the 100
patients, PTH levels were preoperatively determined,
and 22.6 % of the patients (14) had hyperparathyroidism.
The average PTH levels (reference range: 10.0-69.0 ng/
L) for patients with BMIs over 60 kg/m² were 83.15 ng/
L preoperatively, 73.30 ng/L after 6 months and
61.55 ng/L after 18 months (Table 5; 6). Thirty-four
patients (34.0 %) were supplemented with calcium car-
bonate and cholecalciferol, including 15 patientsTable 5 Postoperative course of calcium (mmol/l)
Timeline [months]
BMI [kg/m²]
OP 3 6 12 18 24
35 - 39,9 2,36 2,36 2,37 2,40 2,40 2,44
40 - 49,9 2,38 2,37 2,40 2,35 2,38 2,36
50 - 59,9 2,37 2,35 2,38 2,34 2,35 2,30
≥ 60 2,33 2,44 2,40 2,34 2,35 2,33
Total 2,36 2,37 2,39 2,35 2,36 2,34
Table 6 Postoperative course of parathormone (ng/l)
Timeline [months]
BMI [kg/m²]
OP 3 6 12 18 24
35 - 39,9 44,93 45,45 41,98 42,04 44,70 39,90
40 - 49,9 57,34 65,65 51,73 54,23 56,01 54,94
50 - 59,9 48,98 46,93 53,29 55,95 55,79 56,28
≥ 60 83,15 108,82 73,30 60,41 61,55 64,81
Total 59,55 66,67 56,72 55,13 56,44 56,52
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mentation patients were supplemented with 500 mg cal-
cium with 10 mg cholecalciferol four times daily.
Twenty-four patients (24.0 %) were treated with separate
or additional vitamin D supplementation due to high
levels of PTH, including 9 patients treated preventively
after a second operation.
Under supplementation, a rising concentration of PTH
appeared 3 months after the operation. After 6 months,
a significant decrease in the concentration of PTH was
identified (p= 0.045). Course of PTH levels is shown in
table 6 (Table 6).Albumin SG did not significantly affect the patients’ al-
bumin levels (reference range: 34.0-48.0 g/L) during the
follow-up period.Vitamin B12 Overall, forty-two patients (42.0 %)
received vitamin B12 supplementation. For vitamin B12
supplementation 1000 μg Vitamin B12 monthly was
ordinated. 24 patients with SG as a standalone proced-
ure (24.0 %) were supplemented within the first post-
operative year and 18 patients after RYGBP or DS.
(Table 7). Under supplementation, the vitamin B12 levels
achieved stable average values (reference range: 175–810
pmol/L) during the entire follow-up period.
The 75 patients after SG as a standalone procedure
demonstrated stable and not significantly different vita-
min B12 concentrations (OP: 285.6 pmol/L; 3rd month:Table 7 Necessity of vitamin B12 supplementation during the
BMI
35-39.9 kg/m² 40-49.9 kg/m²
Vitamin B12 [n] [%] [n] %
After OP 0 0.0 0 0.0
After 3 months 1 12.5 4 13.8
After 6 months 0 0.0 2 6.9
After 12 months 0 0.0 1 3.4
After 24 months 0 0.0 0 0.0
After 2nd OP 1 12.5 2 6.9
Total 2 25.0 9 31.0288.1 pmol/L; 6th month: 269.0 pmol/L; 12th month:
253.8 pmol/L; 18th month: 254.2 pmol/L; 24th month:
265.2 pmol/L) (Table 7).
Folic acid Regarding folic acid (reference range: 10.40-
42.40 nmol/L), there was a significant decrease 3 months
after the operation from 18.87 nmol/L to 15.29 nmol/L
(p< 0.0005). 19 patients were supplemented. After
RYGBP or DS 21 patient were given a supplementation
according national and international guidelines. After
the third month following the operation, an increasing
concentration of folic acid was observed with a max-
imum average of 20.96 nmol/L after 24 months. Supple-
mentation was performed with a combination of folic
acid 0.5 mg and iron 40 mg daily.
Discussion
SG is an effective operative method for inducing weight
loss. SG can be performed as the first step of a two-
stage procedure for high-risk patients to reduce the peri-
operative risks of DS or RYGBP.
Literature shows the benefits of LSG compared to lap-
aroscopic gastric banding (LAGB) and laparoscopic
RYGBP. Advantages of SG are non-resection of the pyl-
orus, which prevents dumping syndrome; no intestinal
anastomoses, no risk of developing an internal hernia
and nearly regular intestinal absorption [10]. Complica-
tion rate of SG procedure is still high, especially short
term complications as leakage and staple line insuffi-
ciency influences the complication rate. In literature an
increasing long term complication rate is reported due
to stenosis, gastroesophageal reflux and re-operation
rate due insufficient weight loss, regain of weight or in-
sufficient amelioration of comorbidities [11]. Evidence
based data on nutrient deficiencies, especially vitamin
B12 and iron, after SG is not available.
SG, however, reduces perioperative risks of morbidly
obese patients with BMI> 60 kg/m² as a first step pro-
cedure [12]. The reported initial weight loss after SGfollow-up period
50-59,9 kg/m² ≥ 60 kg/m² Total
[n] [%] [n] [%] [n] [%]
0 0.0 1 4.5 1 1.0
5 12.2 2 9.1 12 12.0
4 9.8 2 9.1 8 8.0
0 0.0 2 9.1 3 3.0
0 0.0 0 0.0 0 0.0
10 24.4 5 22.7 18 18.0
19 46.3 12 54.5 42 42.0
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prospective study of 100 patients, Johnston et al. pre-
sented a %EWL of 60 % after 5 years [15]. That study
group achieved a %EWL of 60.3 % after 12 months and
63.8 % after 24 months.
Over a 24-month period, the entire patient population
experienced continuous weight loss. The weight loss
remained constant (BMI 35.4 kg/m²) in clinical examina-
tions through the 24th months. SG as a single step oper-
ation is suitable for patients with BMIs< 50 kg/m². Only
8.1 % of these patients (3/37) required a second inter-
vention to induce further weight loss within the follow-
up period (vs. 34.9 % with BMI of 50 kg/m²). After
24 months, patients with a BMI between 35 to 39.9 kg/
m² achieved the highest %EWL. Therefore, there was no
correlation between the resected volume of the stomach
and the %EWL. Only one patient (12.5 %) needed to
undergo a second operation for further weight loss.
After 18 months, patients who only underwent SG
demonstrated increased mean weights, which may have
been due to sleeve dilatation. This possibility was con-
sidered by Gluck et al., who presented %EWLs of 67.9 %
after 1 year, 62.4 % after 2 years and 62.2 % after 3 years
for patients after SG with preoperative BMIs between 35
and 43 kg/m² [16].
There is not always sufficient weight loss after SG; in-
sufficient changes in food patterns or potential recidiv-
ism to old food patterns may cause a sleeve dilatation.
One option for treatment may be a re-sleeve operation.
There are inadequate data to properly appraise this op-
tion, and further studies must clarify the utility of this
procedure in comparison to RYGBP or DS as a second
operation.
In addition because of the moderate rate of major
complications of 8.0 % (8/100), SG can be recommended
as a first-step operation before malabsorptive interven-
tions. Regarding postoperative complications, there were
no significant differences among the BMI categories.
However, patients with BMI> 60 kg/m² required a
change to laparotomy significantly more often because
of an insufficient intraabdominal view. Preoperative im-
plantation of a gastric balloon to reduce morbidity for
patients with BMI> 60 kg/m² still needs to be
addressed. Especially in patients with BMI above 60 kg/
m² general complication rate is increasing, due to the
fact of an increased pulmonary complication risk, longer
operation time and a higher risk for renal complications
especially rhabdomyolysis [17].
In this study, there was a 30-day mortality of 0.0 %, a
hospitalization mortality of 1.0 %, and a one-year mor-
tality of 2.0 %. There were 2 patients who did not benefit
from SG. One patient with a preoperative BMI of
50.5 kg/m² first lost weight after SG, but his weight
eventually increased to a higher level than before SG(59.7 kg/m² by the end of the follow-up). An insufficient
change in food patterns and intake of high-calorie foods
appeared to be the cause. The other patient, with a pre-
operative BMI of 55.5 kg/m², died after a prolonged
course with various complications on day 73 after SG.
One other multimorbid patient with a preoperative BMI
of 68.0 kg/m² died 10 months postoperatively. A causal
relationship with SG was excluded after consultation
with the family doctor.
The definitive success rate for SG in this study was
98.0 %, with a mortality of 1.0 % and a non-responder
rate of 1.0 %. Twenty-five percent of the patients in this
study required a second operation via a two-stage pro-
cedure for further weight loss.
Nutritional deficits after LSG are rarely evaluated. In
postoperative course there is no suggestion for vitamin
supplementation. Evidence based data on necessity of sup-
plementation after SG does not exist in literature. After
evaluating nutritional deficiencies, there is no need for
supplementation after SG, although preoperative existing
deficits should be supplemented. Laboratory parameters
should be monitored regularly to detect early nutritional
deficiencies and to initiate appropriate therapies.
Vitamin B12 levels were in the lower third of the refer-
ence range during supplementation. Therefore, it is likely
that without supplementation, vitamin B12 deficiencies
would have occurred. Therefore, a general vitamin B12
supplementation is advisable to avoid pernicious anemia
and to prevent neuropathic pain.
Patients with deficiencies in albumin, vitamin D or cal-
cium have a higher risk of developing osteoporosis; there-
fore, it is recommended that appropriate supplementations
be initiated, even if the concentrations of these para-
meters are only slightly decreased. PTH levels should be
determined to diagnose secondary hyperparathyroidism.
Based on to parameters, iron supplementation should
be initiated similar to the supplementation of folic acid.
Moreover, supplementation of zinc should be based on
symptoms (hair loss, immune deficiency, dry skin).
Medication of zinc and calcium should be suggested to
intake at different times, because zinc reduces calcium
absorption. Supplementation of selenium is not generally
necessary because postoperative deficiencies normalize
on their own without supplementation, and an adequate,
varied food intake seems to be sufficient. Regular deter-
mination of laboratory parameters should be performed
6 months after the operation and semiannually there-
after; if the patient’s weight stabilizes, laboratory para-
meters should be determined once a year.
Conclusions
Our results following SG and those reported in the lit-
erature are promising. Adequate long-term results are
still unavailable because long-term studies (> 6 years)
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are encouraging.
The operative treatment is not comparable among
studies because of a lack of standardization [9]. Also, the
3rd International Consensus Statement on Sleeve Gas-
trectomy could not recommend which part of the an-
trum should be left and to what degree the antrum
should be minimized to achieve a long-term volume re-
duction in the sleeve [8]. Evidence-based data are un-
available concerning the size of the bougie or whether
the use of staple line reinforcement could reduce the
rates of leakage [18].
Our data suggest:
SG is an effective intervention for weight loss. For
patients with a BMI of 35–49.9 kg/m², a single-step
procedure is suitable. For patients with a BMI> 50 kg/
m², SG is suitable as a first-step procedure for reducing
perioperative risks for DS [8; 17].
for patients with BMI> 60 kg/m², preoperative
implantation of a gastric balloon should be discussed
with the aim to reduce morbidity and mortality.
Supplementation of vitamin B12 is indicated and
should generally be initiated after SG.
Supplementation of iron and folic acid should depend
on laboratory parameters for both genders.
A deficiency in albumin was not reproducible in our
patients.
Supplementation of zinc should be based on symptoms.
Substitution of selenium is not necessary.
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